Anzeige
Mehr »
Montag, 18.08.2025 - Börsentäglich über 12.000 News
6,35-Mrd. vs. 30-Mio.-€ - Die Bewertungslücke im Kohlesektor, die kein Investor ignorieren kann
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1J68D | ISIN: CNE100001M79 | Ticker-Symbol: 08HH
Tradegate
18.08.25 | 19:44
2,408 Euro
+2,29 % +0,054
Branche
Pharma
Aktienmarkt
ASIEN
1-Jahres-Chart
SHANGHAI FOSUN PHARMACEUTICAL GROUP CO LTD Chart 1 Jahr
5-Tage-Chart
SHANGHAI FOSUN PHARMACEUTICAL GROUP CO LTD 5-Tage-Chart
RealtimeGeldBriefZeit
2,2882,40620:17
2,2882,40620:19

Aktuelle News zur SHANGHAI FOSUN PHARMACEUTICAL Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DiFOSUN PHARMA (02196): OVERSEAS REGULATORY ANNOUNCEMENT - ANNOUNCEMENT IN RELATION TO THE ACCEPTANCE OF A SUBSIDIARY'S DRUG REGISTRATION APPLICATION16
DiFosun Pharma Rises After Unit Sells Rights to Novel Lung Disease Drug Outside China for USD645 Million5
DiHSI Loses 82Pts at Open; BABA-W Soft; FOSUN PHARMA Up21
DiFOSUN PHARMA Surges 7%+ at Open; Potential Value of Overseas Licensing for Small-Molecule Oral DPP-1 Inhibitor Totals USD645M6
08.08.FOSUN PHARMA (02196): VOLUNTARY ANNOUNCEMENT - COMPLETION OF THE ISSUANCE OF THE SECOND TRANCHE SCIENTIFIC AND TECHNOLOGICAL INNOVATION BONDS FOR 20255
08.08.FOSUN PHARMA (02196): DATE OF BOARD MEETING8
30.07.AriBio Signs Exclusive Licensing Deal with China's Fosun Pharma for Alzheimer's Drug6
SHANGHAI FOSUN PHARMACEUTICAL Aktie jetzt für 0€ handeln
29.07.Fosun Pharma Secures Rights to Novel Alzheimer's Drug in China16
24.07.Dividendenbekanntmachungen (24.07.2025)7.477 Unternehmen  ISIN-Code  Dividende (Währung)  Dividende (EUR)  APTARGROUP INC  US0383361039  0,45 USD  0,3823 EUR  BLOOMSBURY PUBLISHING PLC  GB0033147751  0,1154 GBP  0,1331 EUR  CALNEX SOLUTIONS PLC  GB00BMBK7016  0...
► Artikel lesen
15.07.FOSUN PHARMA (02196): CONNECTED TRANSACTION - CAPITAL REDUCTION OF SUZHOU ANGEL FUND18
11.07.FOSUN PHARMA (02196): OVERSEAS REGULATORY ANNOUNCEMENT - ANNOUNCEMENT IN RELATION TO THE ACCEPTANCE OF A SUBSIDIARY'S DRUG REGISTRATION APPLICATION5
09.07.FOSUN PHARMA (02196): OVERSEAS REGULATORY ANNOUNCEMENT - ANNOUNCEMENT IN RELATION TO THE PROGRESS OF DRUG CLINICAL TRIAL BY A SUBSIDIARY4
07.07.Nature's Sunshine übernimmt nach Anteilsverkauf durch Fosun Pharma die volle Kontrolle über China-Joint-Ventures8
26.06.Fosun Pharma prices $34.25M Nature's Sunshine share sale6
26.06.FOSUN PHARMA (02196): NEXT DAY DISCLOSURE RETURN - SHARE BUYBACK6
24.06.FOSUN PHARMA (02196): POLL RESULTS OF THE RESOLUTIONS PROPOSED AT THE AGM, THE 2025 FIRST A SHAREHOLDERS' CLASS MEETING AND THE 2025 FIRST H SHAREHOLDERS' ...2
24.06.FOSUN PHARMA (02196): FINAL DIVIDEND FOR THE YEAR ENDED 31 DECEMBER 20244
24.06.FOSUN PHARMA (02196): TERMS OF REFERENCE AND IMPLEMENTATION RULES OF THE STRATEGIC COMMITTEE UNDER THE BOARD OF DIRECTORS-
24.06.FOSUN PHARMA (02196): TERMS OF REFERENCE AND IMPLEMENTATION RULES OF THE AUDIT COMMITTEE UNDER THE BOARD OF DIRECTORS-
24.06.FOSUN PHARMA (02196): TERMS OF REFERENCE AND IMPLEMENTATION RULES OF THE NOMINATION COMMITTEE UNDER THE BOARD OF DIRECTORS-
Weiter >>
86 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1